Jae C. Lee
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Safety and efficacy of SNK01 (autologous natural killer cells) in combination with cytotoxic chemotherapy and/or cetuximab after failure of prior tyrosine kinase inhibitor in non-small cell lung cancer: non-clinical mouse model and phase I/IIa clinical study.
Journal: Journal for immunotherapy of cancer
Published: February 28, 2024
Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in patients with recurrent non-small cell lung cancer after definitive concurrent chemoradiation or radiotherapy.
Journal: Journal of cancer research and clinical oncology
Published: June 28, 2022
Assessment of Anti-tumor Efficacy of Osimertinib in Non-Small Cell Lung Cancer Patients by Liquid Biopsy Using Bronchoalveolar Lavage Fluid, Plasma, or Pleural Effusion.
Journal: Cancer research and treatment
Published: July 28, 2021
Contribution of p53 in sensitivity to EGFR tyrosine kinase inhibitors in non-small cell lung cancer.
Contribution of p53 in sensitivity to EGFR tyrosine kinase inhibitors in non-small cell lung cancer.
Journal: Scientific reports
Published: April 19, 2021
Discovery of a novel CDK7 inhibitor YPN-005 in small cell lung cancer.
Journal: European journal of pharmacology
Published: April 08, 2021
Clinical Applications of Liquid Biopsy in Non-Small Cell Lung Cancer Patients: Current Status and Recent Advances in Clinical Practice.
Journal: Journal of clinical medicine
Published: March 18, 2021
Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lung.
Journal: BMC cancer
Published: January 13, 2021
Clinical outcomes of nivolumab in patients with advanced non-small cell lung cancer in real-world practice, with an emphasis on hyper-progressive disease.
Journal: Journal of cancer research and clinical oncology
Published: March 14, 2020
Exceptional pemetrexed sensitivity can predict therapeutic benefit from subsequent chemotherapy in metastatic non-squamous non-small cell lung cancer.
Journal: Journal of cancer research and clinical oncology
Published: April 03, 2019
Comparison of T790M Acquisition Between Patients Treated with Afatinib and Gefitinib as First-Line Therapy: Retrospective Propensity Score Matching Analysis.
Journal: Translational oncology
Published: January 18, 2019
Last Updated: 09/26/2026